We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+7.68%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$413M
AUM Growth
-$3.2M
Cap. Flow
-$14.3M
Cap. Flow %
-3.47%
Top 10 Hldgs %
30.14%
Holding
1,129
New
83
Increased
245
Reduced
309
Closed
247

Top Sells

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$23.5M
2
LIN icon
Linde
LIN
+$8.45M
3
V icon
Visa
V
+$5.42M
4
ALC icon
Alcon
ALC
+$3.14M
5
TMUS icon
T-Mobile US
TMUS
+$3.04M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 19.6%
2 Technology 15.24%
3 Industrials 9.82%
4 Financials 7.82%
5 Healthcare 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBOE icon
426
Cboe Global Markets
CBOE
$30.2B
$119K 0.03%
+916
New +$118K
LEN icon
427
Lennar Class A
LEN
$20.5B
$116K 0.03%
1,030
+665
+182% +$68K
AB icon
428
AllianceBernstein
AB
$3.54B
$112K 0.03%
2,290
MS icon
429
Morgan Stanley
MS
$333B
$111K 0.03%
1,133
-5,600
-83% -$558K
CVS icon
430
CVS Health
CVS
$137B
$111K 0.03%
1,075
+744
+225% +$68.8K
ROAD icon
431
Construction Partners
ROAD
$5.86B
$110K 0.03%
3,749
-12,437
-77% -$434K
NREF
432
NexPoint Real Estate Finance
NREF
$316M
$109K 0.03%
5,680
XBI icon
433
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$108K 0.03%
963
PPLT
434
abrdn Physical Platinum Shares ETF
PPLT
$1.85B
$107K 0.03%
11,910
GH icon
435
Guardant Health
GH
$19.2B
$106K 0.03%
1,061
-1,405
-57% -$145K
KRTX
436
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$105K 0.03%
+803
New +$104K
BLDP
437
Ballard Power Systems
BLDP
$859M
$104K 0.03%
8,261
-10,314
-56% -$156K
SLV icon
438
iShares Silver Trust
SLV
$28.2B
$103K 0.03%
4,799
ALEC icon
439
Alector
ALEC
$169M
$103K 0.02%
4,983
+4,866
+4,159% +$110K
IWN icon
440
iShares Russell 2000 Value ETF
IWN
$14.4B
$102K 0.02%
616
-946
-61% -$158K
EOG icon
441
EOG Resources
EOG
$75.5B
$99.9K 0.02%
1,125
+1,112
+8,554% +$99.9K
PHAT icon
442
Phathom Pharmaceuticals
PHAT
$957M
$99.5K 0.02%
5,058
DSL
443
DoubleLine Income Solutions Fund
DSL
$1.22B
$98.9K 0.02%
6,137
-3,163
-34% -$54.1K
CKPT
444
DELISTED
Checkpoint Therapeutics
CKPT
$97.2K 0.02%
3,126
-1,697
-35% -$56.2K
DLR icon
445
Digital Realty Trust
DLR
$71.8B
$93.4K 0.02%
528
+309
+141% +$49.5K
FRPT icon
446
Freshpet
FRPT
$2.95B
$92K 0.02%
966
-288
-23% -$35.7K
SPG icon
447
Simon Property Group
SPG
$74.7B
$91.2K 0.02%
571
-486
-46% -$74.2K
NAD icon
448
Nuveen Quality Municipal Income Fund
NAD
$2.72B
$89.2K 0.02%
5,537
-2,863
-34% -$44.8K
LVS icon
449
Las Vegas Sands
LVS
$31.6B
$89.1K 0.02%
2,366
-336
-12% -$12.9K
ERAS icon
450
Erasca
ERAS
$6.68B
$87.1K 0.02%
+5,589
New +$95.7K

Similar funds

Exane Derivatives's Q4 2021 Portfolio in Review

As of Q4 2021, Exane Derivatives held 1,129 positions worth $413M, down 0.77% from $417M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Exane Derivatives withdrew a net $14.3M in Q4 2021, closing 247 positions and reducing 309 holdings. Its most notable exit was Visa, an estimated $5.42M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 11% a quarter earlier, followed by Technology and Industrials.

Against the trend, Exane Derivatives opened a new position in EngageSmart, Inc. worth $1.1M.

  • Exane Derivatives's largest Q4 2021 buy was EngageSmart, Inc.: 45,605 shares worth $1.1M.
  • Exane Derivatives added most to Ferrari in Q4 2021, an estimated $21.4M increase.
  • Exane Derivatives's biggest Q4 2021 reduction was UBS Group, cutting an estimated $23.5M.
  • Exane Derivatives fully exited Visa in Q4 2021, selling an estimated $5.42M.
  • Exane Derivatives's ten largest holdings make up 30% of its $413M portfolio in Q4 2021.
  • Exane Derivatives opened 83 new positions and closed 247 in Q4 2021.
  • Exane Derivatives's portfolio value fell 0.77% quarter-over-quarter to $413M.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.